Role of various cytokines and growth factors in pubertal development

Medicine and Sport Science

Volumn 55, Issue , 2010, Pages 14-31

  Casazza, Krista ^a   Hanks, Lynae J ^a   Alvarez, Jessica A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; GHRELIN; GROWTH HORMONE; INSULIN; INTERLEUKIN 6; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; SEX HORMONE; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD; HUMAN; INSULIN RESISTANCE; PHYSIOLOGY; PUBERTY; REFERENCE VALUE;

ADIPOKINES; GHRELIN; GONADAL STEROID HORMONES; GROWTH HORMONE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-6; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PUBERTY; REFERENCE VALUES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84926110530     PISSN: 02545020     EISSN: 16622812     Source Type: Book Series    
DOI: 10.1159/000321969     Document Type: Article

References (67)

1. Hull KL, Harvey S: Growth hormone: a reproductive endocrine-paracrine regulator? Rev Reprod 2000;5:175-182.
2. Guercio G, Rivarola MA, Chaler E, Maceiras M, Belgorosky A: Relationship between the growth hormone/insulin-like growth factor-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal girls. J Clin Endocrinol Metab 2003;88:1389-1393.
3. Leung KC, Johannsson G, Leong GM, Ho KK: Estrogen regulation of growth hormone action. Endocr Rev 2004;25:693-721.
4. Meinhardt UJ, Ho KK: Modulation of growth hormone action by sex steroids. Clin Endocrinol (Oxf) 2006;65:413-422.
5. Meinhardt UJ, Ho KK: Regulation of growth hormone action by gonadal steroids. Endocrinol Metab Clin North Am 2007;36:57-73.
6. Tena-Sempere M: Roles of ghrelin and leptin in the control of reproductive function. Neuroendocrinology 2007;86:229-241.
7. McCann SM, Kimura M, Karanth S, Yu WH, Mastronardi CA, Rettori V: The mechanism of action of cytokines to control the release of hypothalamic and pituitary hormones in infection. Ann NY Acad Sci 2000;917:4-18.
8. Dedoussis GV, Kapiri A, Samara A, et al: Visfatin: the link between inflammation and childhood obesity. Diabetes Care 2009;32:e71.
9. MacRae VE, Wong SC, Farquharson C, Ahmed SF: Cytokine actions in growth disorders associated with pediatric chronic inflammatory diseases (review). Int J Mol Med 2006;18:1011-1018.
10. Belgorosky A, Baquedano MS, Guercio G, Rivarola MA: Expression of the IGF and the aromatase/ estrogen receptor systems in human adrenal tissues from early infancy to late puberty: implications for the development of adrenarche. Rev Endocr Metab Disord 2009;10:51-61.
11. Robson H, Siebler T, Shalet SM, Williams GR: Interactions between GH, IGF-I, glucocorticoids, and thyroid hormones during skeletal growth. Pediatr Res 2002;52:137-147.
12. Misra M, Bredella MA, Tsai P, Mendes N, Miller KK, Klibanski A: Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls. Am J Physiol Endocrinol Metab 2008;295:E385-E392.
13. Misra M, Miller KK, Almazan C, Worley M, Herzog DB, Klibanski A: Hormonal determinants of regional body composition in adolescent girls with anorexia nervosa and controls. J Clin Endocrinol Metab 2005;90:2580-2587.
14. Lin CM, Huang YL, Lin ZY: Influence of gender on serum growth hormone, insulin-like growth factor- I and its binding protein-3 during aging. Yonsei Med J 2009;50:407-413.
15. Lopez-Bermejo A, Khosravi J, Fernandez-Real JM, et al: Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25). Diabetes 2006;55: 2333-2339.
16. Juul A, Dalgaard P, Blum WF, et al: Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 1995;80:2534-2542.
17. Lofqvist C, Andersson E, Gelander L, et al: Reference values for insulin-like growth factor-binding protein- 3 (IGFBP-3) and the ratio of insulin-like growth factor-I to IGFBP-3 throughout childhood and adolescence. J Clin Endocrinol Metab 2005;90: 1420-1427.
18. Kaplan RC, McGinn AP, Pollak MN, et al: Association of total insulin-like growth factor-I, insulinlike growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke. J Clin Endocrinol Metab 2007;92: 1319-1325.
19. Ong KK, Emmett P, Northstone K, et al: Infancy weight gain predicts childhood body fat and age at menarche in girls. J Clin Endocrinol Metab 2009; 94:1527-1532.
20. Attia N, Tamborlane WV, Heptulla R, et al: The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity. J Clin Endocrinol Metab 1998;83:1467-1471.
21. Woelfle JF, Harz K, Roth C: Modulation of circulating IGF-I and IGFBP-3 levels by hormonal regulators of energy homeostasis in obese children. Exp Clin Endocrinol Diabetes 2007;115:17-23.
22. Bhasin S, Woodhouse L, Casaburi R, et al: Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab 2001;281: E1172-E1181.
23. Gibney J, Wolthers T, Johannsson G, Umpleby AM, Ho KK: Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men. Am J Physiol Endocrinol Metab 2005;289:E266-E271.
24. Gibney J, Healy ML, Stolinski M, et al: Effect of growth hormone (GH) on glycerol and free fatty acid metabolism during exhaustive exercise in GH-deficient adults. J Clin Endocrinol Metab 2003; 88:1792-1797.
25. Wolthers T, Hoffman DM, Nugent AG, Duncan MW, Umpleby M, Ho KK: Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women. Am J Physiol Endocrinol Metab 2001;281:E1191-E1196. (Pubitemid 34001193)
26. Klein NA, Battaglia DE, Miller PB, Soules MR: Circulating levels of growth hormone, insulin-like growth factor-I and growth hormone binding protein in normal women of advanced reproductive age. Clin Endocrinol (Oxf) 1996;44:285-292.
27. Smith CP, Archibald HR, Thomas JM, et al: Basal and stimulated insulin levels rise with advancing puberty. Clin Endocrinol (Oxf) 1988;28:7-14.
28. Lee JM: Insulin resistance in children and adolescents. Rev Endocr Metab Disord 2006;7:141-147.
29. Moran A, Jacobs DR Jr, Steinberger J, et al: Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes 1999;48:2039-2044.
30. Potau N, Ibanez L, Sentis M, Carrascosa A: Sexual dimorphism in the maturation of the pituitarygonadal axis, assessed by GnRH agonist challenge. Eur J Endocrinol 1999;141:27-34.
31. Dunaif A: Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774-800.
32. Ibanez L, Potau N, De ZF: Endocrinology and metabolism after premature pubarche in girls. Acta Paediatr Suppl 1999;88:73-77.
33. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS: A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001;50:1714-1719.
34. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402:656-60.
35. Budak E, Fernandez SM, Bellver J, Cervero A, Simon C, Pellicer A: Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system. Fertil Steril 2006;85: 1563-1581.
36. Whatmore AJ, Hall CM, Jones J, Westwood M, Clayton PE: Ghrelin concentrations in healthy children and adolescents. Clin Endocrinol (Oxf) 2003; 59:649-654.
37. Reinehr T: Obesity and thyroid function. Mol Cell Endocrinol 2010;316:165-171.
38. Maccarinelli G, Sibilia V, Torsello A, et al: Ghrelin regulates proliferation and differentiation of osteoblastic cells. J Endocrinol 2005;184:249-256.
39. Frost RA, Lang CH: Alteration of somatotropic function by proinflammatory cytokines. J Anim Sci 2004;82(E-suppl):E100-E109.
40. Pass C, MacRae VE, Ahmed SF, Farquharson C: Inflammatory cytokines and the GH/IGF-I axis: novel actions on bone growth. Cell Biochem Funct 2009;27:119-127.
41. Martos-Moreno GA, Barrios V, Argente J: Normative data for adiponectin, resistin, interleukin 6, and leptin/ receptor ratio in a healthy Spanish pediatric population: relationship with sex steroids. Eur J Endocrinol 2006;155:429-434.
42. Suter KJ, Pohl CR, Wilson ME: Circulating concentrations of nocturnal leptin, growth hormone, and insulin-like growth factor-I increase before the onset of puberty in agonadal male monkeys: potential signals for the initiation of puberty. J Clin Endocrinol Metab 2000;85:808-814.
43. Bluher S, Mantzoros CS: Leptin in humans: lessons from translational research. Am J Clin Nutr 2009;89: 991S-997S.
44. Brandao CM, Lombardi MT, Nishida SK, Hauache OM, Vieira JG: Serum leptin concentration during puberty in healthy nonobese adolescents. Braz J Med Biol Res 2003;36:1293-6.
45. Clayton PE, Gill MS, Hall CM, Tillmann V, Whatmore AJ, Price DA: Serum leptin through childhood and adolescence. Clin Endocrinol (Oxf) 1997;46: 727-33.
46. Federico G, Baroncelli GI, Vanacore T, Fiore L, Saggese G: Pubertal changes in biochemical markers of growth. Horm Res 2003;60:46-51.
47. Matkovic V, Ilich JZ, Badenhop NE, et al: Gain in body fat is inversely related to the nocturnal rise in serum leptin level in young females. J Clin Endocrinol Metab 1997;82:1368-1372. (Pubitemid 27200402)
48. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K: cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 1996;221: 286-289.
49. Jeffery AN, Murphy MJ, Metcalf BS, et al: Adiponectin in childhood. Int J Pediatr Obes 2008;3:130-140.
50. Tsou PL, Jiang YD, Chang CC, et al: Sex-related differences between adiponectin and insulin resistance in schoolchildren. Diabetes Care 2004;27:308-313.
51. Martin TJ, Romas E, Gillespie MT: Interleukins in the control of osteoclast differentiation. Crit Rev Eukaryot Gene Expr 1998;8:107-123.
52. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR: Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 1986;319:516-518.
53. Gaspersic R, Stiblar-Martincic D, Osredkar J, Skaleric U: Influence of subcutaneous administration of recombinant TNF-alpha on ligature-induced periodontitis in rats. J Periodontal Res 2003;38:198-203.
54. Aris RM, Stephens AR, Ontjes DA, et al: Adverse alterations in bone metabolism are associated with lung infection in adults with cystic fibrosis. Am J Respir Crit Care Med 2000;162:1674-1678.
55. Wennberg P, Nordstrom P, Lorentzon R, Lerner UH, Lorentzon M: TNF-alpha gene polymorphism and plasma TNF-alpha levels are related to lumbar spine bone area in healthy female Caucasian adolescents. Eur J Endocrinol 2002;146:629-634.
56. Rees A, Thomas N, Brophy S, Knox G, Williams R: Cross sectional study of childhood obesity and prevalence of risk factors for cardiovascular disease and diabetes in children aged 11-13. BMC Public Health 2009;9:86.
57. McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S: Resistin, central obesity, and type 2 diabetes. Lancet 2002;359:46-47.
58. Li M, Fisette A, Zhao XY, Deng JY, Mi J, Cianflone K: Serum resistin correlates with central obesity but weakly with insulin resistance in Chinese children and adolescents. Int J Obes (Lond) 2009;33:424-439.
59. Gerber M, Boettner A, Seidel B, et al: Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance. J Clin Endocrinol Metab 2005;90:4503-4509.
60. Oh KW, Lee WY, Rhee EJ, et al: The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin Endocrinol (Oxf) 2005;63:131-138.
61. Luk T, Malam Z, Marshall JC: Pre-B cell colonyenhancing factor (PBEF)/visfatin: a novel mediator of innate immunity. J Leukoc Biol 2008;83:804-816.
62. Araki S, Dobashi K, Kubo K, et al: Plasma visfatin concentration as a surrogate marker for visceral fat accumulation in obese children. Obesity (Silver Spring) 2008;16:384-388.
63. Jin H, Jiang B, Tang J, et al: Serum visfatin concentrations in obese adolescents and its correlation with age and high-density lipoprotein cholesterol. Diabetes Res Clin Pract 2008;79:412-418.
64. Haider DG, Holzer G, Schaller G, et al: The adipokine visfatin is markedly elevated in obese children. J Pediatr Gastroenterol Nutr 2006;43: 548-549.
65. Peng XD, Xie H, Zhao Q, Wu XP, Sun ZQ, Liao EY: Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Clin Chim Acta 2008;387:31-35.
66. Blum WF: Leptin: the voice of the adipose tissue. Horm Res 1997;48(suppl 4):2-8.
67. Kettaneh A, Heude B, Oppert JM, et al: Serum adiponectin is related to plasma high-density lipoprotein cholesterol but not to plasma insulin-concentration in healthy children: the FLVS II study. Metabolism 2006;55:1171-1176.